img

Biosimilar Testing and Development Services Market Status and Trend Analysis 2017-2034 (COVID-19 Version)


Published on: 2024-01-04 | No of Pages : 108 | Industry : Life & Medical

Publisher : 9 | Format : PDF

Biosimilar Testing and Development Services Market Status and Trend Analysis 2017-2034 (COVID-19 Version)

Summary

Further key aspects of the report indicate that
Chapter 1Research ScopeProduct Definition, Type, End-Use & Methodology
Chapter 2Global Industry Summary
Chapter 3Market Dynamics
Chapter 4Global Market Segmentation by region, type and End-Use
Chapter 5North America Market Segmentation by region, type and End-Use
Chapter 6Europe Market Segmentation by region, type and End-Use
Chapter 7Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8South America Market Segmentation by region, type and End-Use
Chapter 9Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10Market Competition by Companies
Chapter 11Market forecast and environment forecast.
Chapter 12Industry Summary.

The global Biosimilar Testing and Development Services market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.


Based on the type of product

the global Biosimilar Testing and Development Services market segmented into
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays

Based on the end-use

the global Biosimilar Testing and Development Services market classified into
PK assay
Tiered Immunogenicity testing
NAb assays

Based on geography

the global Biosimilar Testing and Development Services market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are


Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich

Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BIOSIMILAR TESTING AND DEVELOPMENT SERVICES INDUSTRY
2.1 Summary about Biosimilar Testing and Development Services Industry
2.2 Biosimilar Testing and Development Services Market Trends
2.2.1 Biosimilar Testing and Development Services Production & Consumption Trends
2.2.2 Biosimilar Testing and Development Services Demand Structure Trends
2.3 Biosimilar Testing and Development Services Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Effector Binding
4.2.2 ELISA
4.2.3 Kinetic Binding Assays
4.2.4 ADCC & CDC Cell-Based Assays
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 PK assay
4.3.2 Tiered Immunogenicity testing
4.3.3 NAb assays
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Effector Binding
5.2.2 ELISA
5.2.3 Kinetic Binding Assays
5.2.4 ADCC & CDC Cell-Based Assays
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 PK assay
5.3.2 Tiered Immunogenicity testing
5.3.3 NAb assays
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Effector Binding
6.2.2 ELISA
6.2.3 Kinetic Binding Assays
6.2.4 ADCC & CDC Cell-Based Assays
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 PK assay
6.3.2 Tiered Immunogenicity testing
6.3.3 NAb assays
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Effector Binding
7.2.2 ELISA
7.2.3 Kinetic Binding Assays
7.2.4 ADCC & CDC Cell-Based Assays
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 PK assay
7.3.2 Tiered Immunogenicity testing
7.3.3 NAb assays
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Effector Binding
8.2.2 ELISA
8.2.3 Kinetic Binding Assays
8.2.4 ADCC & CDC Cell-Based Assays
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 PK assay
8.3.2 Tiered Immunogenicity testing
8.3.3 NAb assays
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Effector Binding
9.2.2 ELISA
9.2.3 Kinetic Binding Assays
9.2.4 ADCC & CDC Cell-Based Assays
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 PK assay
9.3.2 Tiered Immunogenicity testing
9.3.3 NAb assays
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Eurofins Scientific
10.1.2 SGS
10.1.3 Charles River Laboratories
10.1.4 Pharmaceutical Product Development
10.1.5 Exova
10.1.6 Source BioScience
10.1.7 Intertek Group
10.1.8 Medistri
10.1.9 Pace Analytical Services
10.1.10 Sigma-Aldrich
10.2 Biosimilar Testing and Development Services Sales Date of Major Players (2017-2020e)
10.2.1 Eurofins Scientific
10.2.2 SGS
10.2.3 Charles River Laboratories
10.2.4 Pharmaceutical Product Development
10.2.5 Exova
10.2.6 Source BioScience
10.2.7 Intertek Group
10.2.8 Medistri
10.2.9 Pace Analytical Services
10.2.10 Sigma-Aldrich
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Biosimilar Testing and Development Services Product Type Overview
Table Biosimilar Testing and Development Services Product Type Market Share List
Table Biosimilar Testing and Development Services Product Type of Major Players
Table Brief Introduction of Eurofins Scientific
Table Brief Introduction of SGS
Table Brief Introduction of Charles River Laboratories
Table Brief Introduction of Pharmaceutical Product Development
Table Brief Introduction of Exova
Table Brief Introduction of Source BioScience
Table Brief Introduction of Intertek Group
Table Brief Introduction of Medistri
Table Brief Introduction of Pace Analytical Services
Table Brief Introduction of Sigma-Aldrich
Table Products & Services of Eurofins Scientific
Table Products & Services of SGS
Table Products & Services of Charles River Laboratories
Table Products & Services of Pharmaceutical Product Development
Table Products & Services of Exova
Table Products & Services of Source BioScience
Table Products & Services of Intertek Group
Table Products & Services of Medistri
Table Products & Services of Pace Analytical Services
Table Products & Services of Sigma-Aldrich
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Biosimilar Testing and Development Services Market Forecast (Million USD) by Region 2021f-2026f
Table Global Biosimilar Testing and Development Services Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Biosimilar Testing and Development Services Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Biosimilar Testing and Development Services Market Forecast (Million USD) Share by Demand 2021f-2026f